Clinical Trial Update: Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 clinical trials evaluating approaches to reduce hippocampal hyperactivity and improve cognition in schizophrenia have completed, with result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: VA Office of Research and Development | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-07-14